The story of Viagra and the pharmaceutical industry presents a challenging picture for potential investors. Initially, copyright's remarkable drug transformed the treatment of erectile dysfunction, producing significant profits and influencing the contemporary pharmaceutical landscape. However, intellectual property expiration and the appearance of